Piper Sandler Cuts DexCom (NASDAQ:DXCM) Price Target to $90.00
DexCom (NASDAQ:DXCM – Free Report) had its price objective reduced by Piper Sandler from $100.00 to $90.00 in a research report report published on Friday,Benzinga reports. Piper Sandler currently has an overweight rating on the medical device company’s stock. A number of other equities analysts also recently weighed in on DXCM. Wells Fargo & Company […]
DexCom (NASDAQ:DXCM – Free Report) had its price objective reduced by Piper Sandler from $100.00 to $90.00 in a research report report published on Friday,Benzinga reports. Piper Sandler currently has an overweight rating on the medical device company’s stock. A number of other equities analysts also recently weighed in on DXCM. Wells Fargo & Company […]
